FDA Panel Supports More Clarity in NSCLC Perioperative Immunotherapy Trials

Published Date: 29 Jul 2024

Committee unanimously backs mandating trial design to distinguish effects of therapy phases

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Novel probes to label macrophages associated with cancer progression using a selective dye

2.

Poor agreement between diagnostic tests for breast cancer-related lymphedema

3.

Researchers use AI to monitor side effects of chemotherapy and support families dealing with pediatric cancer.

4.

Off-the-Shelf Drug Matches CAR-T Effects in Refractory Lupus

5.

FDA Panel Supports More Clarity in NSCLC Perioperative Immunotherapy Trials


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot